BNTX logo

BioNTech SE (BNTX) Operating Profit

Annual Operating Profit:

-$695.96M-$1.68B(-171.08%)
December 31, 2024

Summary

  • As of today, BNTX annual operating income is -$695.96 million, with the most recent change of -$1.68 billion (-171.08%) on December 31, 2024.
  • During the last 3 years, BNTX annual operating profit has fallen by -$21.54 billion (-103.34%).
  • BNTX annual operating profit is now -103.34% below its all-time high of $20.84 billion, reached on December 31, 2021.

Performance

BNTX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Quarterly Operating Profit:

$743.43M+$1.36B(+219.88%)
September 30, 2025

Summary

  • As of today, BNTX quarterly operating income is $743.43 million, with the most recent change of +$1.36 billion (+219.88%) on September 30, 2025.
  • Over the past year, BNTX quarterly operating profit has increased by +$342.35 million (+85.36%).
  • BNTX quarterly operating profit is now -86.10% below its all-time high of $5.35 billion, reached on September 30, 2021.

Performance

BNTX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM Operating Profit:

-$236.50M+$342.35M(+59.14%)
September 30, 2025

Summary

  • As of today, BNTX TTM operating income is -$236.50 million, with the most recent change of +$342.35 million (+59.14%) on September 30, 2025.
  • Over the past year, BNTX TTM operating profit has increased by +$30.10 million (+11.29%).
  • BNTX TTM operating profit is now -101.14% below its all-time high of $20.80 billion, reached on March 31, 2022.

Performance

BNTX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

BNTX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-171.1%+85.4%+11.3%
3Y3 Years-103.3%-66.6%-101.6%
5Y5 Years-238.8%+426.7%+46.4%

BNTX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-103.3%at low-78.9%+198.7%-101.6%+66.8%
5Y5-Year-103.3%at low-86.1%+198.7%-101.1%+66.8%
All-TimeAll-Time-103.3%at low-86.1%+198.7%-101.1%+66.8%

BNTX Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$743.43M(+219.9%)
-$236.50M(+59.1%)
Jun 2025
-
-$620.14M(-7.7%)
-$578.85M(+18.7%)
Mar 2025
-
-$575.91M(-366.5%)
-$711.76M(-3.0%)
Dec 2024
-$695.96M(-171.1%)
$216.11M(-46.1%)
-$691.11M(-159.2%)
Sep 2024
-
$401.08M(+153.3%)
-$266.60M(+54.4%)
Jun 2024
-
-$753.04M(-35.6%)
-$584.24M(-51.5%)
Mar 2024
-
-$555.27M(-186.7%)
-$385.60M(-141.1%)
Dec 2023
$979.17M(-93.9%)
$640.63M(+667.8%)
$937.25M(-75.4%)
Sep 2023
-
$83.44M(+115.0%)
$3.81B(-36.0%)
Jun 2023
-
-$554.40M(-172.2%)
$5.96B(-30.1%)
Mar 2023
-
$767.58M(-78.2%)
$8.52B(-34.5%)
Dec 2022
$15.97B(-23.4%)
$3.52B(+57.9%)
$13.01B(-11.3%)
Sep 2022
-
$2.23B(+11.1%)
$14.67B(-17.5%)
Jun 2022
-
$2.01B(-61.9%)
$17.79B(-14.5%)
Mar 2022
-
$5.26B(+1.6%)
$20.80B(+19.5%)
DateAnnualQuarterlyTTM
Dec 2021
$20.84B(+6958.7%)
$5.18B(-3.2%)
$17.41B(+42.2%)
Sep 2021
-
$5.35B(+6.6%)
$12.24B(+83.6%)
Jun 2021
-
$5.02B(+168.5%)
$6.67B(+327.9%)
Mar 2021
-
$1.87B(>+9900.0%)
$1.56B(+513.4%)
Dec 2020
-$303.92M(-47.9%)
$5.57M(+102.4%)
-$376.82M(+14.6%)
Sep 2020
-
-$227.56M(-155.2%)
-$441.00M(-73.3%)
Jun 2020
-
-$89.16M(-35.8%)
-$254.44M(-16.2%)
Mar 2020
-
-$65.67M(-12.1%)
-$219.05M(-7.8%)
Dec 2019
-$205.43M(-197.5%)
-$58.61M(-42.9%)
-$203.17M(-37.9%)
Sep 2019
-
-$41.00M(+23.8%)
-$147.36M(-12.1%)
Jun 2019
-
-$53.77M(-8.0%)
-$131.51M(-69.2%)
Mar 2019
-
-$49.79M(-1683.5%)
-$77.74M(-178.2%)
Dec 2018
-$69.05M(+3.3%)
-$2.79M(+88.9%)
-$27.94M(-11.1%)
Sep 2018
-
-$25.15M
-$25.15M
Dec 2017
-$71.44M
-
-

FAQ

  • What is BioNTech SE annual operating income?
  • What is the all-time high annual operating profit for BioNTech SE?
  • What is BioNTech SE annual operating profit year-on-year change?
  • What is BioNTech SE quarterly operating income?
  • What is the all-time high quarterly operating profit for BioNTech SE?
  • What is BioNTech SE quarterly operating profit year-on-year change?
  • What is BioNTech SE TTM operating income?
  • What is the all-time high TTM operating profit for BioNTech SE?
  • What is BioNTech SE TTM operating profit year-on-year change?

What is BioNTech SE annual operating income?

The current annual operating profit of BNTX is -$695.96M

What is the all-time high annual operating profit for BioNTech SE?

BioNTech SE all-time high annual operating income is $20.84B

What is BioNTech SE annual operating profit year-on-year change?

Over the past year, BNTX annual operating income has changed by -$1.68B (-171.08%)

What is BioNTech SE quarterly operating income?

The current quarterly operating profit of BNTX is $743.43M

What is the all-time high quarterly operating profit for BioNTech SE?

BioNTech SE all-time high quarterly operating income is $5.35B

What is BioNTech SE quarterly operating profit year-on-year change?

Over the past year, BNTX quarterly operating income has changed by +$342.35M (+85.36%)

What is BioNTech SE TTM operating income?

The current TTM operating profit of BNTX is -$236.50M

What is the all-time high TTM operating profit for BioNTech SE?

BioNTech SE all-time high TTM operating income is $20.80B

What is BioNTech SE TTM operating profit year-on-year change?

Over the past year, BNTX TTM operating income has changed by +$30.10M (+11.29%)
On this page